Symptom Interactions in Cancer and Immune Disorders (R21)

The summary for the Symptom Interactions in Cancer and Immune Disorders (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Symptom Interactions in Cancer and Immune Disorders (R21): -Purpose. This funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Cancer Institute (NCI), National Institute on Aging (NIA), National Institutes of Health (NIH), solicits grant applications from applicant organizations that propose to (a) identify and assess biobehavioral interactions among two or more related and co-occurring symptoms; (b) characterize mechanisms and pathways underlying the symptom interactions; (c) elucidate the level of interaction necessary for categorization as a symptom cluster; and/or (d) design and test interventions targeted to interacting or clustered symptoms that are hypothesized to lead to beneficial patient outcomes. A rationale for the choice of symptoms is needed, not just co-occurrence of two or more symptoms, and they must be associated with a target disease or syndrome or its treatment. Studies at any point in the disease trajectory, or during the survivorship period are encouraged. -Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-08-121, that encourages applications under the R01 grant mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Symptom Interactions in Cancer and Immune Disorders (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-08-122
Type of Funding: Grant
CFDA Numbers: 93.36193.399
CFDA Descriptions: Nursing Research 93.399 Cancer Control
Current Application Deadline: No deadline provided
Original Application Deadline: May 07, 2011
Posted Date: Mar 28, 2008
Creation Date: Mar 28, 2008
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses City or township governments State governments County governments Independent school districts Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith-based or Community-based Organizations Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non-domestic (non-U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) is not endorsed by, or affiliated with, any government agency. Copyright ©2019